Laddar...
Inhaled glycopyrrolate for the treatment of chronic obstructive pulmonary disease
Long-acting muscarinic antagonists (LAMAs), along with long-acting β(2)-agonists (LABAs), are the mainstay for treatment of patients with COPD. Glycopyrrolate, or glycopyrronium bromide, like other LAMAs, inhibits parasympathetic nerve impulses by selectively blocking the binding of acetylcholine to...
Sparad:
| I publikationen: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Dove Medical Press
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6003532/ https://ncbi.nlm.nih.gov/pubmed/29928118 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S162646 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|